Nuclear factor-kappaB decoy: infiltrating the heart of the matter in inflammatory heart disease.
Liu
P P
PP
Le
J
J
Nian
M
M
D000818:Animals; D001327:Autoimmune Diseases / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D016207:Cytokines / Q000037:antagonists & inhibitors* / Q000096:biosynthesis / Q000235:genetics; D004195:Disease Models, Animal; D015870:Gene Expression / Q000187:drug effects; D015316:Genetic Therapy; D015726:Giant Cells / Q000276:immunology; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics / Q000378:metabolism; D008081:Liposomes; D051379:Mice; D009205:Myocarditis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D009841:Oligonucleotides / Q000008:administration & dosage*; D011401:Promoter Regions, Genetic / Q000187:drug effects; D013601:T-Lymphocytes / Q000276:immunology
D016207:Cytokines; D008081:Liposomes; D016328:NF-kappa B; D009841:Oligonucleotides; D018799:Intercellular Adhesion Molecule-1; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse